BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 2010
View Archived Issues
Pharmasset selects anti-HCV purine nucleotide prodrugs to develop
Read More
Yissum claims new MMP-2 inhibitors
Read More
Early control of blood pressure achieved by telmisartan/nifedipine GIST, TALENT data suggest
Read More
MyD88 inhibitor STJJ induces tolerance of skin transplants in mice
Read More
Metformin has beneficial effects in patients with chronic heart failure
Read More
Phase II and III trials examine SIR-Spheres in patients with refractory colorectal liver metastases
Read More
STX-100 receives FDA orphan drug designation for IPF
Read More
Glenmark discovers novel TRPA1 receptor antagonist GRC-17536
Read More
FDA grants orphan drug designation to BMN-701 for Pompe's disease
Read More
New GHS-R antagonists claimed by sanofi-aventis
Read More
Celgene discovers new isotopologues of lenalidomide
Read More
New GlyT-1 inhibitors identified by sanofi-aventis
Read More
Janssen presents novel antibacterial agents
Read More
BTG to receive marketing rights for Nycomed's CroFab and DigiFab
Read More
Health Canada approves Sativex for spasticity due to MS
Read More
FDA approves Suboxone sublingual film
Read More
Meda to acquire specialty pharmaceutical company, Alaven
Read More
Pluristem's PLX cells included in diastolic heart failure program
Read More
Treatment with MP4OX effective in severe trauma patients
Read More
Positive outcome to decentralized procedure for European approval of Twinject
Read More
PEARL-HF study shows reduced hyperkalemia with RLY-5016
Read More
FDA approves Lumigan 0.01% for reducing IOP in glaucoma patients
Read More
ImmuneRegen to submit proposal for funding Homspera development
Read More
Otonomy closes Series B financing
Read More
Neurotech initiates phase I AAD-2004 trial targeting AD, PD and ALS
Read More